Top compounds associated with response to LDLRAD2


Feature Type Standardized
Nominal ANOVA
mRNA GW843682X CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA B02 CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA MST-312 CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.11 0.0002
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA PD-0325901 gCSI pan-cancer AAC 0.22 0.0003
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.11 0.0003
Download CSV